Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Dec 17, 2021 10:02am
125 Views
Post# 34240247

RE:How much could be a buyout?

RE:How much could be a buyout?
OakTreeforest39 wrote:

Any guess?
1 or 2 billion?? More ...less? 

i think GA already talk about that in comparison with it's former success!
thanks



If this is a serious question, and not just something to prompt speculation to fuel excitement about the stock, to pump up the price, then there are established approaches to value a company like this:
 
1.  Multiple of capital EBI TDA.  This does require revenue however, and ventrapoint does not have any operational revenue at this point-the only cash coming in is from financing's
 
2.  Valuation pre-revenue for a startup
Now on this board, the typical approach is to simply pick a number out of the air like 100 million, I billion, 2 billion etc. however, there has been no basis for this other than "I think I heard this on a video mention by George", or "another company went for this so"…
 
Speaking of this approach, 1 of the videos did mention the buyout by TomTech, for around 100 million, which would if you took these numbers put VPT buy out at  around 60 cents, given that the dilution has now had a doubling of shares since that time(and yes dilution most definitely matters)

On this thread, jopumper, took an unrelated company, made an assumption about how much it was worth based on a recent financing, and added a 60% premium without any basis at all. 

One of the caveats in making these kinds of comparisons, is you are assuming that the company you are comparing to, has similar characteristics as VPT has.  In this case, it was not all the case as  the company, CARDIOLOGS, that was brought out, had 20 million customers, whereas VPT is giving out machines and how many PAYING customers that they have?
 
Still this type of approach can be used, and the kind of factors you look at include:
A.  Number of users (Is it really 25 "placements")
B.  |Stage of the company
 
C.  Margins
D. Competition risk (patent gone from UWash-so its just the database\)
 
D.  Management
 
E.  Laaunchplan etc. etc. etc.

There are models to do this like the Berkus method, cost to duplicate, and many others, but my take is that this board really is not interested in deep dives on methods or data.
 
So just go ahead and pick a number!
<< Previous
Bullboard Posts
Next >>